share_log

RW: Registration Withdrawal Request

RW: Registration Withdrawal Request

RW：註冊提款請求
美股SEC公告 ·  2024/12/20 06:04

Moomoo AI 已提取核心訊息

HeartSciences Inc., formerly known as Heart Test Laboratories, Inc., has requested the withdrawal of its Registration Statement on Form S-1 (File No. 333-272501) from the U.S. Securities and Exchange Commission (SEC). The request was made on December 19, 2024, pursuant to Rule 477 under the Securities Act of 1933.The Registration Statement, originally filed on June 7, 2023, had not been declared effective by the SEC. The company confirmed that no securities were issued or sold under this Registration Statement or the public offering prospectus contained therein. HeartSciences has also requested that all fees paid to the SEC in connection with the filing be credited for future use, in accordance with Rule 457(p) of the Securities Act.The withdrawal request was submitted by Danielle Watson, Chief Financial Officer of HeartSciences. The company's legal counsel, Jonathan Shechter and Sasha Ablovatskiy from Foley Shechter, are available for any further information or clarification regarding this withdrawal request.
HeartSciences Inc., formerly known as Heart Test Laboratories, Inc., has requested the withdrawal of its Registration Statement on Form S-1 (File No. 333-272501) from the U.S. Securities and Exchange Commission (SEC). The request was made on December 19, 2024, pursuant to Rule 477 under the Securities Act of 1933.The Registration Statement, originally filed on June 7, 2023, had not been declared effective by the SEC. The company confirmed that no securities were issued or sold under this Registration Statement or the public offering prospectus contained therein. HeartSciences has also requested that all fees paid to the SEC in connection with the filing be credited for future use, in accordance with Rule 457(p) of the Securities Act.The withdrawal request was submitted by Danielle Watson, Chief Financial Officer of HeartSciences. The company's legal counsel, Jonathan Shechter and Sasha Ablovatskiy from Foley Shechter, are available for any further information or clarification regarding this withdrawal request.
HeartSciences Inc.，前稱Heart Test Laboratories, Inc.，已請求從美國證券交易委員會（SEC）撤回其在S-1表格上的註冊聲明（文件編號333-272501）。該請求於2024年12月19日根據《1933年證券法》第477條提出。該註冊聲明最初於2023年6月7日提交，但尚未被SEC宣佈有效。公司確認，此註冊聲明或其包含的公開發行招股說明書下沒有發行或出售任何證券。HeartSciences還請求將與該申請相關的所有費用退還，以備將來使用，依據《證券法》第457(p)條。撤回請求由HeartSciences首席財務官丹妮爾·沃森提交。公司的法律顧問喬納森·謝赫特和薩莎·阿布洛瓦茨基來自Foley Shechter，隨時可以提供有關此撤回請求的進一步信息或澄清。
HeartSciences Inc.，前稱Heart Test Laboratories, Inc.，已請求從美國證券交易委員會（SEC）撤回其在S-1表格上的註冊聲明（文件編號333-272501）。該請求於2024年12月19日根據《1933年證券法》第477條提出。該註冊聲明最初於2023年6月7日提交，但尚未被SEC宣佈有效。公司確認，此註冊聲明或其包含的公開發行招股說明書下沒有發行或出售任何證券。HeartSciences還請求將與該申請相關的所有費用退還，以備將來使用，依據《證券法》第457(p)條。撤回請求由HeartSciences首席財務官丹妮爾·沃森提交。公司的法律顧問喬納森·謝赫特和薩莎·阿布洛瓦茨基來自Foley Shechter，隨時可以提供有關此撤回請求的進一步信息或澄清。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間